Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic exoskeleton may boost arm recovery after stroke

NCT ID NCT07834255

Symptom relief Sponsor: Lokman Hekim University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 23, 2026 · Updated 1 time

Summary

Researchers are testing whether adding robot-assisted arm training to standard physiotherapy helps people recover better after a recent stroke. The trial enrolls 36 adults who had a stroke 2 to 4 weeks earlier and have shoulder pain. Half receive conventional therapy alone, while the other half combine conventional therapy with sessions using the ArmeoPower robotic exoskeleton, which guides arm movements through game-like exercises. The study measures changes in arm movement, muscle tone, shoulder pain, thinking skills, shoulder joint alignment, and independence in daily activities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robot-assisted upper extremity therapy using the ArmeoPower exoskeleton device
What this could lead to
If it works, robot-assisted training could become a standard add-on to physiotherapy, helping stroke survivors regain arm function and independence sooner.
What could go wrong
The trial is small, with only 36 participants, and robot-assisted therapy may not outperform conventional physiotherapy alone. Some patients may find the robotic device uncomfortable or difficult to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Jan 2026

Finished

May 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Stroke history between 2-4 weeks * No prior stroke * Age between 35-70 years * No prior diagnosis of orthopedic upper extremity disease or orthopedic upper extremity surgery * No prior diagnosis of neurological disease * Cognitive status suitable for rehabilitation * At a supported sitting level for the treatment group * Having shoulder pain as assessed by the Brief Pain Inventory before the study Exclusion Criteria: * More than 1 month having passed since the stroke * Having experienced more than one stroke * Having a prior diagnosis of Impingement syndrome, Frozen shoulder, Rotator cuff injury * Having a prior diagnosis of Alzheimer's, Dementia, Parkinson's disease * Failure to provide the necessary participation in evaluation and treatment within the scope of the study * Suffering a second stroke during the study process * Discharge before completing the study process * Lack of willingness to participate in the study * Loss of voluntary participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhagic stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemiplegia hemorrhagic stroke ischemic stroke Shoulder Pain stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhagic stroke Ischemic stroke Stroke Subacute stroke

Contacts and locations

Locations

  • Ankara Bilkent City Hospital Physical Medicine and Rehabilitation Hospital

    Ankara, Çankaya, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.